Last 48 quarters of trend data · Basic Materials · Chemicals - Specialty
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Innospec Inc.'s quarterly P/E stands at 15.0x, down 17.2% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has expanded 8.6% YoY to 10.8x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 17.25 | 14.96 | 10.02 | 37.10 | 22.36 | 18.08 | — | 21.26 | 24.92 | 19.54 | 20.41 | 16.27 | 21.65 |
| — | -17.2% | — | +74.5% | -10.2% | -7.4% | — | +30.6% | +15.1% | +1.2% | -19.0% | +17.8% | +16.6% | |
| P/S Ratio | 1.13 | 1.00 | 1.04 | 1.09 | 1.20 | 1.35 | 1.48 | 1.60 | 1.78 | 1.62 | 1.56 | 1.38 | 1.31 |
| — | -25.8% | -29.5% | -32.1% | -32.8% | -16.5% | -5.1% | +16.3% | +36.5% | +28.5% | +24.1% | +32.1% | +2.1% | |
| P/B Ratio | 1.51 | 1.27 | 1.43 | 1.48 | 1.62 | 1.88 | 2.27 | 2.28 | 2.59 | 2.72 | 2.68 | 2.27 | 2.29 |
| — | -32.6% | -37.3% | -35.2% | -37.6% | -31.0% | -15.3% | +0.4% | +13.2% | +14.9% | +8.8% | +15.7% | +2.4% | |
| P/FCF | 22.78 | 52.13 | 10.16 | 19.22 | — | 29.88 | 141.03 | 10.79 | — | 12.21 | 15.07 | 14.04 | 16.64 |
| — | +74.5% | -92.8% | +78.2% | — | +144.8% | +835.8% | -23.2% | — | — | +48.4% | -21.0% | — | |
| EV / EBITDA | 8.76 | 10.79 | 7.51 | 9.88 | 10.40 | 9.94 | 12.11 | 11.38 | 14.04 | 12.34 | 13.38 | 11.54 | 13.54 |
| — | +8.6% | -38.0% | -13.1% | -25.9% | -19.4% | -9.5% | -1.4% | +3.7% | +0.7% | +21.1% | +33.3% | +29.4% | |
| EV / EBIT | 11.53 | — | 9.01 | 36.96 | 13.49 | 12.34 | 16.84 | 13.47 | 17.61 | 14.20 | 16.45 | 13.68 | 16.64 |
| — | — | -46.5% | +174.4% | -23.4% | -13.1% | +2.4% | -1.5% | +5.9% | -1.6% | +20.6% | +31.5% | +19.9% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Innospec Inc.'s operating margin was 8.1% in Q1 2026, down 2.3 pp QoQ and down 1.6 pp YoY. Gross margin contracted 4.0% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 27.7% | 27.3% | 28.0% | 26.4% | 28.0% | 28.4% | 29.2% | 28.0% | 29.2% | 31.1% | 31.5% | 29.6% | 31.3% |
| — | -4.0% | -4.2% | -5.6% | -4.0% | -8.8% | -7.3% | -5.3% | -6.8% | +7.3% | +6.0% | -2.8% | +4.7% | |
| Operating Margin | 8.8% | 8.1% | 10.3% | 7.0% | 7.8% | 9.6% | 8.8% | 10.3% | 9.4% | 10.1% | 9.0% | 9.0% | 7.1% |
| — | -16.5% | +17.4% | -31.6% | -16.6% | -4.5% | -2.1% | +13.9% | +31.4% | +25.5% | -1.4% | -7.6% | -28.1% | |
| Net Margin | 6.6% | 6.7% | 10.4% | 2.9% | 5.3% | 7.4% | -15.1% | 7.5% | 7.2% | 8.3% | 7.6% | 8.4% | 6.0% |
| — | -9.9% | +169.0% | -61.2% | -25.5% | -10.1% | -297.4% | -10.8% | +19.2% | +27.0% | +53.0% | +12.0% | -12.9% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 9.1% | 2.2% | 3.6% | 1.0% | 1.8% | 2.6% | -5.7% | 2.7% | 2.6% | 3.5% | 3.3% | 3.5% | 2.7% |
| — | -16.8% | +162.9% | -63.8% | -30.1% | -25.4% | -272.2% | -22.5% | -1.4% | +13.2% | +38.8% | -1.6% | -12.1% | |
| ROA | 6.5% | 1.7% | 2.6% | 0.7% | 1.3% | 1.9% | -4.0% | 1.9% | 1.8% | 2.4% | 2.3% | 2.4% | 1.8% |
| — | -10.9% | +165.5% | -62.5% | -27.8% | -22.3% | -275.4% | -21.3% | +1.7% | +17.0% | +45.9% | +3.7% | -9.8% | |
| ROIC | 11.2% | 2.4% | 3.2% | 2.2% | 2.5% | 3.2% | 3.1% | 3.4% | 3.1% | 3.9% | 3.4% | 3.2% | 2.6% |
| — | -26.7% | +1.7% | -37.2% | -21.0% | -17.2% | -8.0% | +5.8% | +18.6% | +21.3% | -3.5% | -10.1% | -22.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Innospec Inc.'s Debt/EBITDA ratio is 1.4x, down from 1.6x last quarter — comfortably within a safe range. The current ratio has improved 9.2% YoY to 2.98x, strengthening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.07 | 0.04 | 0.07 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| — | +0.8% | +81.9% | +2.7% | -5.8% | -4.6% | -6.1% | -2.8% | -4.1% | -18.9% | -9.7% | -10.0% | -9.1% | |
| Debt / EBITDA | 0.44 | 1.39 | 1.58 | 1.14 | 1.09 | 0.83 | 0.86 | 0.81 | 0.93 | 0.72 | 0.83 | 0.82 | 1.04 |
| — | +66.7% | +83.5% | +41.4% | +16.9% | +16.1% | +4.5% | -1.8% | -10.8% | -26.5% | +1.8% | +8.1% | +19.5% | |
| Current Ratio | 2.79 | 2.98 | 2.79 | 2.78 | 2.87 | 2.73 | 2.58 | 2.59 | 2.63 | 2.50 | 2.38 | 2.51 | 2.34 |
| — | +9.2% | +8.3% | +7.3% | +9.1% | +9.2% | +8.0% | +3.1% | +12.5% | +9.1% | +10.9% | +13.1% | +8.2% | |
| Quick Ratio | 1.88 | 2.02 | 1.88 | 1.81 | 1.88 | 1.85 | 1.77 | 1.73 | 1.69 | 1.67 | 1.58 | 1.55 | 1.36 |
| — | +9.4% | +6.2% | +4.3% | +10.8% | +10.9% | +12.0% | +12.0% | +24.1% | +25.0% | +28.1% | +26.9% | +15.2% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | 119.67 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying IOSP stock.
Innospec Inc.'s current P/E is 17.2x. The average P/E over the last 4 quarters is 21.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Innospec Inc.'s current operating margin is 8.8%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Innospec Inc.'s business trajectory between earnings reports.